919.84 USD
+1.91 (+0.21%)
ARGX gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 533 industry peers in the Biotechnology industry. ARGX is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. ARGX is not overvalued while it is showing excellent growth. This is an interesting combination. With these ratings, ARGX could be worth investigating further for growth investing!.
1. Profitability
1.1 Basic Checks
ARGX had positive earnings in the past year.
In the past year ARGX had a positive cash flow from operations.
ARGX had negative earnings in 4 of the past 5 years.
ARGX had a negative operating cash flow in each of the past 5 years.
1.2 Ratios
ARGX has a better Return On Assets (17.84%) than 96.25% of its industry peers.
With an excellent Return On Equity value of 21.00%, ARGX belongs to the best of the industry, outperforming 96.06% of the companies in the same industry.
ARGX's Return On Invested Capital of 6.01% is amongst the best of the industry. ARGX outperforms 92.31% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 17.84% | ||
| ROE | 21% | ||
| ROIC | 6.01% |
ROA(3y)-5.23%
ROA(5y)-11.34%
ROE(3y)-5.76%
ROE(5y)-13.95%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
ARGX's Profit Margin of 41.97% is amongst the best of the industry. ARGX outperforms 97.75% of its industry peers.
Looking at the Operating Margin, with a value of 15.30%, ARGX belongs to the top of the industry, outperforming 93.62% of the companies in the same industry.
ARGX's Gross Margin of 89.40% is amongst the best of the industry. ARGX outperforms 90.99% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 15.3% | ||
| PM (TTM) | 41.97% | ||
| GM | 89.4% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so ARGX is destroying value.
The number of shares outstanding for ARGX has been increased compared to 1 year ago.
The number of shares outstanding for ARGX has been increased compared to 5 years ago.
Compared to 1 year ago, ARGX has a worse debt to assets ratio.
2.2 Solvency
ARGX has an Altman-Z score of 32.83. This indicates that ARGX is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 32.83, ARGX belongs to the top of the industry, outperforming 94.37% of the companies in the same industry.
The Debt to FCF ratio of ARGX is 0.14, which is an excellent value as it means it would take ARGX, only 0.14 years of fcf income to pay off all of its debts.
With an excellent Debt to FCF ratio value of 0.14, ARGX belongs to the best of the industry, outperforming 95.50% of the companies in the same industry.
A Debt/Equity ratio of 0.01 indicates that ARGX is not too dependend on debt financing.
ARGX has a Debt to Equity ratio (0.01) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.01 | ||
| Debt/FCF | 0.14 | ||
| Altman-Z | 32.83 |
ROIC/WACC0.81
WACC7.43%
2.3 Liquidity
ARGX has a Current Ratio of 5.60. This indicates that ARGX is financially healthy and has no problem in meeting its short term obligations.
ARGX has a Current ratio (5.60) which is in line with its industry peers.
ARGX has a Quick Ratio of 5.27. This indicates that ARGX is financially healthy and has no problem in meeting its short term obligations.
ARGX has a Quick ratio (5.27) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 5.6 | ||
| Quick Ratio | 5.27 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 1512.50% over the past year.
The Revenue has grown by 64.65% in the past year. This is a very strong growth!
The Revenue has been growing by 94.61% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)1512.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%272.66%
Revenue 1Y (TTM)64.65%
Revenue growth 3Y63.92%
Revenue growth 5Y94.61%
Sales Q2Q%95.51%
3.2 Future
Based on estimates for the next years, ARGX will show a very strong growth in Earnings Per Share. The EPS will grow by 106.11% on average per year.
The Revenue is expected to grow by 33.99% on average over the next years. This is a very strong growth
EPS Next Y867.29%
EPS Next 2Y297.24%
EPS Next 3Y171.03%
EPS Next 5Y106.11%
Revenue Next Year89.57%
Revenue Next 2Y60.07%
Revenue Next 3Y45.87%
Revenue Next 5Y33.99%
3.3 Evolution
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 68.59, ARGX can be considered very expensive at the moment.
89.49% of the companies in the same industry are more expensive than ARGX, based on the Price/Earnings ratio.
Compared to an average S&P500 Price/Earnings ratio of 25.98, ARGX is valued quite expensively.
With a Price/Forward Earnings ratio of 31.22, ARGX can be considered very expensive at the moment.
90.99% of the companies in the same industry are more expensive than ARGX, based on the Price/Forward Earnings ratio.
The average S&P500 Price/Forward Earnings ratio is at 35.79. ARGX is around the same levels.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 68.59 | ||
| Fwd PE | 31.22 |
4.2 Price Multiples
ARGX's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. ARGX is cheaper than 89.87% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, ARGX is valued cheaper than 90.62% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 183.45 | ||
| EV/EBITDA | 103.9 |
4.3 Compensation for Growth
ARGX's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
ARGX's earnings are expected to grow with 171.03% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.08
PEG (5Y)N/A
EPS Next 2Y297.24%
EPS Next 3Y171.03%
5. Dividend
5.1 Amount
No dividends for ARGX!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
NASDAQ:ARGX (11/26/2025, 12:38:58 PM)
919.84
+1.91 (+0.21%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)
Earnings (Next)
Inst Owners41.51%
Inst Owner Change2.31%
Ins Owners0.12%
Ins Owner ChangeN/A
Market Cap56.63B
Revenue(TTM)3.60B
Net Income(TTM)1.28B
Analysts84.8
Price Target963.18 (4.71%)
Short Float %2.76%
Short Ratio4.71
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)15.16%
Min EPS beat(2)7.11%
Max EPS beat(2)23.2%
EPS beat(4)3
Avg EPS beat(4)3962.36%
Min EPS beat(4)-38.07%
Max EPS beat(4)15857.2%
EPS beat(8)5
Avg EPS beat(8)1996.71%
EPS beat(12)8
Avg EPS beat(12)1343.38%
EPS beat(16)12
Avg EPS beat(16)1012.62%
Revenue beat(2)1
Avg Revenue beat(2)3.68%
Min Revenue beat(2)-0.81%
Max Revenue beat(2)8.17%
Revenue beat(4)3
Avg Revenue beat(4)5.02%
Min Revenue beat(4)-0.81%
Max Revenue beat(4)8.17%
Revenue beat(8)6
Avg Revenue beat(8)5.96%
Revenue beat(12)10
Avg Revenue beat(12)14.45%
Revenue beat(16)13
Avg Revenue beat(16)17.87%
PT rev (1m)12.87%
PT rev (3m)15.78%
EPS NQ rev (1m)0.26%
EPS NQ rev (3m)-0.23%
EPS NY rev (1m)8.14%
EPS NY rev (3m)13.96%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)1.41%
Revenue NY rev (1m)2.3%
Revenue NY rev (3m)4.68%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 68.59 | ||
| Fwd PE | 31.22 | ||
| P/S | 18.56 | ||
| P/FCF | 183.45 | ||
| P/OCF | 140.27 | ||
| P/B | 9.29 | ||
| P/tB | 9.64 | ||
| EV/EBITDA | 103.9 |
EPS(TTM)13.41
EY1.46%
EPS(NY)29.46
Fwd EY3.2%
FCF(TTM)5.01
FCFY0.55%
OCF(TTM)6.56
OCFY0.71%
SpS49.55
BVpS99.01
TBVpS95.45
PEG (NY)0.08
PEG (5Y)N/A
Graham Number172.84
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 17.84% | ||
| ROE | 21% | ||
| ROCE | 7.61% | ||
| ROIC | 6.01% | ||
| ROICexc | 16.72% | ||
| ROICexgc | 18.56% | ||
| OM | 15.3% | ||
| PM (TTM) | 41.97% | ||
| GM | 89.4% | ||
| FCFM | 10.12% |
ROA(3y)-5.23%
ROA(5y)-11.34%
ROE(3y)-5.76%
ROE(5y)-13.95%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.43
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.01 | ||
| Debt/FCF | 0.14 | ||
| Debt/EBITDA | 0.07 | ||
| Cap/Depr | 428.74% | ||
| Cap/Sales | 3.12% | ||
| Interest Coverage | 519.07 | ||
| Cash Conversion | 82.6% | ||
| Profit Quality | 24.11% | ||
| Current Ratio | 5.6 | ||
| Quick Ratio | 5.27 | ||
| Altman-Z | 32.83 |
F-Score5
WACC7.43%
ROIC/WACC0.81
Cap/Depr(3y)176.19%
Cap/Depr(5y)545.91%
Cap/Sales(3y)10.66%
Cap/Sales(5y)13.77%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)1512.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%272.66%
EPS Next Y867.29%
EPS Next 2Y297.24%
EPS Next 3Y171.03%
EPS Next 5Y106.11%
Revenue 1Y (TTM)64.65%
Revenue growth 3Y63.92%
Revenue growth 5Y94.61%
Sales Q2Q%95.51%
Revenue Next Year89.57%
Revenue Next 2Y60.07%
Revenue Next 3Y45.87%
Revenue Next 5Y33.99%
EBIT growth 1Y207%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year1305.72%
EBIT Next 3Y205.97%
EBIT Next 5Y121.7%
FCF growth 1Y140.74%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y161.79%
OCF growth 3YN/A
OCF growth 5YN/A
ARGENX SE - ADR / ARGX FAQ
What is the fundamental rating for ARGX stock?
ChartMill assigns a fundamental rating of 6 / 10 to ARGX.
What is the valuation status of ARGENX SE - ADR (ARGX) stock?
ChartMill assigns a valuation rating of 6 / 10 to ARGENX SE - ADR (ARGX). This can be considered as Fairly Valued.
Can you provide the profitability details for ARGENX SE - ADR?
ARGENX SE - ADR (ARGX) has a profitability rating of 5 / 10.
Can you provide the expected EPS growth for ARGX stock?
The Earnings per Share (EPS) of ARGENX SE - ADR (ARGX) is expected to grow by 867.29% in the next year.